D Hilliard

847 total citations
3 papers, 461 citations indexed

About

D Hilliard is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, D Hilliard has authored 3 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Pharmacology and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in D Hilliard's work include Inflammatory mediators and NSAID effects (1 paper), Pharmacological Receptor Mechanisms and Effects (1 paper) and Cancer therapeutics and mechanisms (1 paper). D Hilliard is often cited by papers focused on Inflammatory mediators and NSAID effects (1 paper), Pharmacological Receptor Mechanisms and Effects (1 paper) and Cancer therapeutics and mechanisms (1 paper). D Hilliard collaborates with scholars based in United States, Belgium and Canada. D Hilliard's co-authors include Michael Tanen, Gary Herman, C. Melinda Stevens, Arthur Bergman, Karen Snyder, Koen Vandyck, Wesley Tanaka, Bingming Yi, Kathleen M. Metters and Anne Van Hecken and has published in prestigious journals such as Clinical Pharmacology & Therapeutics.

In The Last Decade

D Hilliard

3 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Hilliard United States 3 364 145 134 134 98 3 461
Deborah Hilliard United States 5 297 0.8× 132 0.9× 107 0.8× 151 1.1× 116 1.2× 5 532
Silke Retlich Germany 12 460 1.3× 155 1.1× 187 1.4× 189 1.4× 67 0.7× 18 567
Barry Koplowitz United States 8 199 0.5× 105 0.7× 127 0.9× 84 0.6× 45 0.5× 14 408
Floriane Cressier Switzerland 7 283 0.8× 125 0.9× 174 1.3× 57 0.4× 54 0.6× 9 377
Andreas Greischel Germany 11 214 0.6× 50 0.3× 107 0.8× 164 1.2× 39 0.4× 16 382
Franck Poitiers France 7 179 0.5× 193 1.3× 124 0.9× 81 0.6× 67 0.7× 8 507
Bingming Yi United States 8 796 2.2× 297 2.0× 290 2.2× 320 2.4× 160 1.6× 14 940
Ulrike Graefe‐Mody Germany 15 760 2.1× 303 2.1× 319 2.4× 291 2.2× 99 1.0× 19 861
Carolyn Mickel United States 4 793 2.2× 322 2.2× 373 2.8× 213 1.6× 183 1.9× 5 931
Robin O'Connor‐Semmes United States 13 214 0.6× 153 1.1× 157 1.2× 60 0.4× 55 0.6× 18 527

Countries citing papers authored by D Hilliard

Since Specialization
Citations

This map shows the geographic impact of D Hilliard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Hilliard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Hilliard more than expected).

Fields of papers citing papers by D Hilliard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Hilliard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Hilliard. The network helps show where D Hilliard may publish in the future.

Co-authorship network of co-authors of D Hilliard

This figure shows the co-authorship network connecting the top 25 collaborators of D Hilliard. A scholar is included among the top collaborators of D Hilliard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Hilliard. D Hilliard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Lai, Eseng, Inge De Lepeleire, Fang Liu, et al.. (2007). Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist. Clinical Pharmacology & Therapeutics. 83(6). 840–847. 41 indexed citations
2.
Herman, Gary, C. Melinda Stevens, Koen Vandyck, et al.. (2005). Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses. Clinical Pharmacology & Therapeutics. 78(6). 675–688. 414 indexed citations
3.
Ehrich, Elliot, D Hilliard, Arturo G. Porras, et al.. (1999). Demonstration of specific COX-2 inhibition by MK-966 in humans with supratherapeutic doses. Clinical Pharmacology & Therapeutics. 65(2). 164–164. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah Hilliard Breakdown of academic impact, for papers by Silke Retlich Breakdown of academic impact, for papers by Barry Koplowitz Breakdown of academic impact, for papers by Floriane Cressier Breakdown of academic impact, for papers by Andreas Greischel Breakdown of academic impact, for papers by Franck Poitiers Breakdown of academic impact, for papers by Bingming Yi Breakdown of academic impact, for papers by Ulrike Graefe‐Mody Breakdown of academic impact, for papers by Carolyn Mickel Breakdown of academic impact, for papers by Robin O'Connor‐Semmes
Rankless by CCL
2026